New Synthetic Psychedelic Drug Hits the Streets

Parents, educators and doctors of teens need to be aware of the latest synthetic drug to hit the streets of America: 2C – I or “Smiles”. 2C – I is a short-acting synthetic psychedelic with relatively little human use experience.

The “2C” group is a class of potent psychedelic synthetics and the high has been described by users as a combination between ecstasy and LSD. The drug is available in powder, liquid and tablet forms.

There are multiple poison center reports of adverse effects and overdoses in North Dakota, Indiana and Minnesota. Due to its drug class and potency, adverse effects of 2C – I have included fast heart rates, high blood pressure, seizures, and strokes; and the drug is suspected in two teen deaths in North Dakota.

The drug 2C – I has been classified as a Schedule I substance by the DEA, which makes it illegal to possess and sell. However, it may still be available illicitly and the drug’s structure may have been altered to get around legal prohibition with unpredictable effects. There are currently no rapid tests to detect 2C – I in the body and, like other synthetic and illicitly manufactured and marketed drugs, the actual composition of the product and its effects and side-effects, both short and long-term, are usually unknown.

If synthetic drug abuse is suspected, please call the New Mexico Poison Center for treatment advice: 1-800-222-1222. If the victim is having seizures, is unconscious or having trouble breathing, call 911 immediately.


Contact: Luke Frank, 272-3322

Related Stories

NAMI New Mexico Annual 5k Walk

NAMI New Mexico Annual 5k Walk

The Sandoval Regional Medical Center (SRMC) is gearing up to sup­port the National Alliance on Mental Illness (NAMI) through its annual 5k walk on Saturday, May 11 at Balloon Fiesta Field. In years past, SRMC staff, their friends and family have come together to raise money and awareness to help aid in the fight to overcome the obstacles of mental illness.
Center for Healthcare Equity in Kidney Disease Kickoff Event

Center for Healthcare Equity in Kidney Disease Kickoff Event

On Thursday, April 25 CHEK-D will hold a recognition and kickoff event, with a talk and presentation by Dr. Richard Larson, Vice Chancellor for Research, and Dr. Larissa Myaskovsky, CHEK-D Director, from 9 – 10 a.m. in Domenici North Wing room 2710.
UNM Distinguished Diversity Scholar Luncheon and Talk

UNM Distinguished Diversity Scholar Luncheon and Talk

UNM HSC is honored to continue our partnership with Professor Alford. We would like to invite everyone to join us as she presents the UNM Distinguished Diversity Scholar luncheon talk: Enhancing Wellness By Honoring Our Humanity on Friday, April 26.